Christopher V. SmithKline: Impact On Pharma — And Beyond

Law360, New York (June 29, 2012, 1:09 PM EDT) -- The U.S. Supreme Court’s June 18, 2012, decision in Christopher v. SmithKline Beecham Corp.[1] holding that pharmaceutical sales representatives (PSRs) were properly classified as exempt outside sales employees represents not only a significant victory for the pharmaceutical industry and employers generally, but also will have a far-reaching impact on federal agencies by limiting their ability to effectuate new interpretations of federal statutes and regulations via amicus briefs.

Moreover, the decision calls into serious question the applicability of the oft-repeated mantra that Fair Labor Standards Act exemptions...
To view the full article, register now.